scispace - formally typeset
E

Eva S. Schernhammer

Researcher at Medical University of Vienna

Publications -  298
Citations -  22977

Eva S. Schernhammer is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 68, co-authored 265 publications receiving 19787 citations. Previous affiliations of Eva S. Schernhammer include University of Vienna & Duke University.

Papers
More filters
Journal ArticleDOI

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

Madalene Earp, +161 more
- 06 Jul 2018 - 
TL;DR: Investigating variants in 88 small GTPase genes in germline DNA of 18,736 EOC patients and 26,138 controls of European ancestry found two ARHGEF10L variants were located in super-enhancer regions and that AKAP6 rs927062 was associated with expression of G TPase gene ARHGAP5 (Rho GTPases activating protein 5).
Journal ArticleDOI

Night shift work and cardiovascular disease biomarkers in female nurses.

TL;DR: In this article, the authors used quantile regression to estimate differences in biomarker levels by shift work history, adjusting for potential confounders, and found suggestive evidence of adverse short-term and long-term effects of night shift work on select cardiovascular disease biomarkers.
Journal ArticleDOI

Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983–2017)

TL;DR: In this paper , the authors investigated overall and subgroup-specific female breast cancer rates to provide a comprehensive analysis of trends over several decades using nationwide cancer registry data on 163,694 cases of breast cancer in Austria (1983-2017).
Journal ArticleDOI

Impact of the 1st and 2nd Wave of the COVID-19 Pandemic on Primary or Revision Total Hip and Knee Arthroplasty-A Cross-Sectional Single Center Study.

TL;DR: In this paper, the authors evaluated the number of primary and revision total joint arthroplasties (TJA/rTJA) in 2020 compared to 2019 and observed a reduction of 15.8% and 18.6% on the primary TJAs and rTJAs, respectively, in the first and second waves of the COVID-19 pandemic.